Publikationen, an denen er mitarbeitet Álvaro Arjona Sánchez (1)

2021

  1. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1